YOUR BUSINESS AUTHORITY
Springfield, MO
A drug that's said to be the biggest advance in treating depression since the introduction of Prozac in 1987 is nearing approval by the U.S. Food and Drug Administration.
Johnson & Johnson’s esketamine, a close chemical cousin of the anesthetic ketamine, on Thursday was recommended by a panel of outside experts.
The fast-acting antidepressant is administered through a nasal spray.
Read more from Bloomberg.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Timeshare exit company owner sentenced for tax evasion
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.